When B-cell lymphoma returns after successful treatment, recognizing the signs early and understanding the diagnostic process can make a significant difference in managing the disease and exploring new treatment possibilities.
Introduction: Who Should Seek Diagnostics and When
If you have been treated for B-cell lymphoma and achieved remission, you may wonder when you should seek diagnostic testing to check if the disease has come back. Relapsed lymphoma refers to cancer that returns after a period of remission, which doctors usually define as lasting at least six months without any evidence of disease on tests and scans. Understanding when to contact your healthcare team is crucial for catching any recurrence early.[5][13]
Most relapses of aggressive B-cell lymphomas, such as diffuse large B-cell lymphoma (DLBCL), happen within the first two years after completing treatment. Research shows that between 30 and 40 percent of people who initially respond to treatment will experience their cancer returning within this timeframe. Some people have what doctors call early relapse, which occurs less than two years after diagnosis, while others experience late relapse, which happens more than two years after their initial diagnosis.[4][9][14]
You should contact your doctor if you notice any worrying symptoms between your scheduled follow-up appointments. Studies have found that most people who experience a relapse have symptoms when the cancer returns. In one research study, 67 percent of participants were experiencing symptoms when they were diagnosed with relapsed disease. These symptoms are often similar to those you may have experienced before your initial diagnosis, though some may be related to other health conditions or illnesses.[3]
Even if you feel well, regular follow-up appointments with your healthcare team are essential. Your doctor will create a schedule of check-ups and tests based on your specific type of lymphoma, how you responded to treatment, and your individual risk factors. These appointments help catch any signs of recurrence before you develop symptoms.
Diagnostic Methods for Identifying Recurrent B-Cell Lymphoma
When doctors suspect that B-cell lymphoma has returned, they use several diagnostic methods to confirm the recurrence and determine the extent of the disease. These tests help distinguish lymphoma from other conditions that can cause similar symptoms, such as infections or other health problems.
Physical Examination and Medical History
Your doctor will begin by taking a detailed medical history and performing a physical examination. They will ask about any symptoms you are experiencing and how long you have had them. During the physical exam, your doctor will carefully check for swollen lymph nodes, which are one of the most common signs of relapsed lymphoma. These lumps can often be felt underneath your skin, particularly in your neck, armpits, and groin, and are usually painless.[3]
Your doctor may also check for other physical signs, such as an enlarged liver or spleen, and assess your overall health. This examination provides important clues about whether further testing is needed.
Blood Tests
Blood tests are an important part of diagnosing recurrent B-cell lymphoma. These tests can reveal abnormalities in your blood cell counts and help your doctor understand how the disease may be affecting your body. A complete blood count (CBC) measures the levels of different types of blood cells, including white blood cells, red blood cells, and platelets. Changes in these counts can suggest that lymphoma has returned.[1]
Your doctor may also order other blood tests to check your overall health, including tests that measure liver and kidney function. These results help determine whether the lymphoma is affecting other organs in your body.
Biopsy
A biopsy is the most definitive way to confirm that lymphoma has relapsed. During a biopsy, your doctor removes a small sample of tissue from a swollen lymph node or another area where lymphoma is suspected. This tissue is then examined under a microscope by a specialist called a pathologist, who looks for cancer cells and determines the specific type of lymphoma.[7]
Doctors strongly recommend repeating a biopsy when they suspect relapsed lymphoma, even if you had one before. This is because the characteristics of the cancer cells can sometimes change over time, and understanding these changes helps doctors choose the most appropriate treatment. Additionally, imaging scans like PET scans can sometimes give false-positive results in people who do not have active disease, so a biopsy provides certainty.[7]
Imaging Tests
Imaging tests create detailed pictures of the inside of your body and help doctors see where the lymphoma has returned and how extensive it is. Several types of imaging may be used to diagnose recurrent B-cell lymphoma.
Positron emission tomography (PET) scans are particularly useful for detecting lymphoma. During a PET scan, you receive a small amount of radioactive material through an injection. Cancer cells absorb more of this material than normal cells, causing them to show up as bright spots on the scan. PET scans can detect lymphoma throughout your body and are especially helpful for finding disease in lymph nodes and other organs.[1]
Computed tomography (CT) scans use X-rays to create detailed cross-sectional images of your body. These scans show the size and location of lymph nodes and can reveal whether lymphoma has spread to organs like your liver, spleen, or lungs. CT scans are often combined with PET scans to provide comprehensive information about the disease.[1]
Ultrasound uses sound waves to create images of organs and tissues. Your doctor may use ultrasound to examine swollen lymph nodes, particularly those deep inside your abdomen. This test is non-invasive and does not involve radiation, making it a safe option for repeated use.
Bone Marrow Biopsy
If your doctor suspects that lymphoma has spread to your bone marrow, they may recommend a bone marrow biopsy. During this procedure, a small sample of bone marrow is removed, usually from your hip bone, and examined under a microscope. This test helps determine whether lymphoma cells are present in your bone marrow, which can affect treatment decisions and prognosis.[1]
Additional Diagnostic Tests
Depending on your symptoms and the suspected location of recurrent lymphoma, your doctor may order additional tests. For example, if you have abdominal pain, an endoscopy might be performed to examine your digestive tract. This procedure involves inserting a thin, flexible tube with a camera through your mouth to view your esophagus, stomach, and upper intestines.
If lymphoma is suspected in your chest, a chest X-ray or specialized imaging may be needed. In some cases, fluid samples from around your lungs or abdomen may be collected and tested for the presence of lymphoma cells.
Diagnostics for Clinical Trial Qualification
Clinical trials offer access to new and potentially more effective treatments for people with relapsed or refractory B-cell lymphoma. However, to participate in these trials, you must meet specific criteria, and diagnostic tests play a crucial role in determining your eligibility.
Confirming Disease Status
Most clinical trials require confirmation that your lymphoma has relapsed or is refractory to previous treatment. Refractory lymphoma refers to disease that does not respond to treatment or responds only briefly. To confirm this, doctors need recent biopsy results showing active lymphoma. The biopsy must typically be performed within a certain timeframe before enrollment in the trial, often within a few weeks or months.[7]
Clinical trials may have strict definitions of what qualifies as relapsed or refractory disease. For example, some trials focus on patients who relapsed within a specific time period after completing treatment or after undergoing stem cell transplantation. Your medical records and treatment history help researchers determine whether you meet these criteria.
Baseline Imaging and Laboratory Tests
Before you can join a clinical trial, you will undergo a series of baseline tests to measure the extent of your disease and your overall health. These tests provide a starting point that researchers use to evaluate how well the treatment is working during the trial.
PET scans and CT scans are commonly required to document the size and location of lymphoma in your body before treatment begins. These imaging studies are repeated at specific intervals during the trial to assess whether the disease is shrinking, staying stable, or growing. Consistent and accurate imaging is essential for measuring treatment response.[7]
Blood tests are also part of the baseline assessment for clinical trials. These tests check your blood cell counts, liver and kidney function, and other important markers of health. Some trials require specific laboratory values to ensure that participants can safely tolerate the experimental treatment. For example, if a trial involves a treatment that can affect blood cell production, you may need to have adequate levels of red blood cells, white blood cells, and platelets before enrollment.
Molecular and Genetic Testing
Some clinical trials for recurrent B-cell lymphoma require molecular or genetic testing of your cancer cells. These tests look for specific genetic changes or proteins that may predict how well you will respond to a particular treatment. For example, certain trials focus on patients whose lymphoma cells have specific genetic abnormalities, such as changes in the MYC or BCL2 genes, which are associated with more aggressive disease.[17]
Molecular testing is typically performed on tissue obtained from your most recent biopsy. The results help researchers match you with treatments that are most likely to be effective for your specific type of lymphoma. This approach, known as personalized medicine, aims to improve outcomes by tailoring treatment to the unique characteristics of your cancer.
Performance Status Assessment
Clinical trials evaluate your overall physical condition using a measurement called performance status. This assessment helps researchers determine whether you are well enough to participate in the trial and tolerate the proposed treatment. Performance status is usually measured using standardized scales that rate your ability to perform daily activities.
A higher performance status means you are more active and able to care for yourself, while a lower status indicates that you need more assistance with daily tasks. Most clinical trials require participants to have a certain minimum performance status to ensure their safety during the study.
Exclusion Criteria and Additional Testing
Clinical trials often have exclusion criteria that prevent certain people from participating, even if they have relapsed lymphoma. These criteria are designed to protect participants and ensure that the trial results are accurate. Common exclusion criteria include having another active cancer, severe heart or lung disease, uncontrolled infections, or certain blood test abnormalities.
To check for these conditions, you may undergo additional diagnostic tests before enrolling in a trial. For example, you might have an electrocardiogram (ECG) to assess your heart function or a pulmonary function test to evaluate your lungs. These tests help ensure that you can safely receive the experimental treatment.
Monitoring During the Trial
Once you are enrolled in a clinical trial, regular diagnostic testing continues throughout your participation. This ongoing monitoring helps researchers track how your lymphoma responds to treatment and detect any side effects early. You will have scheduled follow-up visits that include physical examinations, blood tests, and imaging studies.
The frequency of these tests depends on the specific trial protocol. Some trials require very frequent monitoring, while others have less intensive schedules. Understanding the testing requirements before you enroll helps you prepare for the commitment involved in participating in a clinical trial.
